Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)

v3.24.1
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Warrants to purchase Common Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 2,301,250 2,301,250
Earnout shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 438,800 438,800
Unvested RSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Antidilutive securities 568,570 655,882